Long term results after low dose ocular irradiation for choroidal haemangiomas
Open Access
- 1 April 1997
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 81 (4), 267-273
- https://doi.org/10.1136/bjo.81.4.267
Abstract
AIM/BACKGROUND The most common choice of treatment for choroidal haemangiomas (CH) in the past has been the employment of scatter photocoagulation of the surface. This management often requires repetitive treatment or additional invasive management due to massive exudative detachment of the retina. The aim of this retrospective study was to investigate the outcome of the alternative application of low dose external beam irradiation with high energetic photons on these tumours. METHODS A total absorbed dose of 20 Gy was applied to a total of 51 symptomatic eyes: 36 with a circumscribed CH of the posterior pole and 15 with diffuse CH as part of the Sturge–Weber syndrome. The indication for treatment was an exudative retinal detachment including or threatening the fovea. The mean follow up times in each group were 4.5 and 5.3 years, respectively. Out of a group of 33 patients from whom reliable data could be derived, 17 had symptoms lasting longer than 6 months. RESULTS In 23 cases (63.8%) with circumscribed CH complete resolution of the subretinal fluid was achieved; the remaining 13 cases (36.2%) showed residual serous detachment distant to the fovea. The visual acuity improved by two or more lines in 14 cases (38.9%), remained stable in 14 cases (38.9%), and decreased in eight cases (22.2%). The functional success was dependent on the lag duration between onset of first subjective symptoms and treatment. The morphological results with diffuse CH were similar to those of the group of circumscribed CH. The visual acuity (VA) at last examination was improved in seven cases (46.6%); in the remaining eight cases, VA was unchanged or had deteriorated. The poor functional outcome in the latter was mainly attributable to secondary glaucoma. CONCLUSION External beam irradiation is a useful and a low invasive therapeutic option for CH. A successful functional outcome is dependent on the time delay between first onset of symptoms and the beginning of therapy, the formation of subretinal fibrosis, and also on secondary glaucoma in the case of Sturge–Weber syndrome.Keywords
This publication has 25 references indexed in Scilit:
- Choroidal HemangiomasPublished by Elsevier BV ,2009
- Clinical Features and Management of Choroidal Hemangiomas, Including Those Occurring in Association with Sturge-Weber SyndromePublished by Springer Science and Business Media LLC ,1993
- LOW DOSE OCULAR IRRADIATION FOR DIFFUSE CHOROIDAL HEMANGIOMAS ASSOCIATED WITH BULLOUS NONRHEGMATOGENOUS RETINAL DETACHMENTRetina, 1991
- New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastomaAlbrecht von Graefes Archiv für Ophthalmologie, 1990
- Circumscribed Choroidal HemangiomasAmerican Journal of Ophthalmology, 1989
- Radiotherapy in benign orbital disease. I: Complicated ocular angiomas.British Journal of Ophthalmology, 1988
- Die erfolgreiche Behandlung eines Aderhauthämangioms mit Sekundärveränderungen bei Sturge-Weber-SyndromKlinische Monatsblätter für Augenheilkunde, 1984
- Diagnostik und Therapie des AderhauthämangiomsKlinische Monatsblätter für Augenheilkunde, 1980
- Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of the literatureSurvey of Ophthalmology, 1976
- An Aid in the Differential Diagnosis of Intraocular TumorsInternational Ophthalmology Clinics, 1972